D. E. Shaw & Co., Inc. - PHASEBIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$31,000
-87.3%
11,796
-85.0%
0.00%
Q3 2021$244,000
+269.7%
78,547
+344.4%
0.00%
Q2 2021$66,00017,6740.00%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 1,607,044$5,400,0000.70%
NEA Management Company, LLC 6,643,704$22,323,0000.59%
DAFNA Capital Management LLC 320,542$1,077,0000.32%
Platform Technology Partners 141,025$474,0000.23%
Parkman Healthcare Partners LLC 110,547$371,0000.10%
Rock Springs Capital Management LP 1,314,374$4,416,0000.09%
GSA CAPITAL PARTNERS LLP 140,341$472,0000.08%
SABBY MANAGEMENT, LLC 65,000$218,0000.04%
Virtu Financial LLC 28,821$97,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,600$429,0000.01%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders